EMEA-001151-PIP02-17
Key facts
| Active substance |
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/0059/2018
|
| PIP number |
EMEA-001151-PIP02-17
|
| Pharmaceutical form(s) |
Modified-release tablet
|
| Condition(s) / indication(s) |
Treatment of type 2 diabetes mellitus
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
AstraZeneca AB
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions/indications
|